StockData
Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc. (RANI) stock

RANINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3036% above fair value
$0.51−0.07 (-11.97%)

Close on Nov 20, 2026Market cap $71.24MP/E –Yield –

Rani Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Rani Therapeutics

Rani Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Rani Therapeutics figures

See a number that looks wrong?